PERRY ANDREW (Chief Commercial Officer) sold 9.4% of their position (8.15K shares) of G1 THERAPEUTICS, INC. on the open market
Open‑market sale worth $39.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/15/2024ACC: 0001562180-24-004064
Officer· Chief Commercial Officer
Since Aug 2021
-8.15K
Net shares
Net seller
$39.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.15K
Price / share
$4.79
Trade value
$39.03K
% of position
9.4%
5/13/2024
87.10K→78.95K
Total
Net shares
−8.15K
Net value
-$39.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/13/2024 | S · Sale | −8.15K | $4.79 | $39.03K | 9.4% | 87.10K | 78.95K |
| Total | −8.15K | -$39.03K | ||||||
Derivative Transactions0
No derivative transactions reported